Original articleConstitutional p53 mutations associated with brain tumors in young adults
References (61)
- et al.
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
Cell
(1990) - et al.
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
Cell
(1993) - et al.
Human chromosome 17 NotI linking clones and their use in long-range restriction mapping of the Miller-Dieker chromosome region (MDCR) in 17p13.3
Genomics
(1990) - et al.
Timing and role of p53 gene mutation in the recurrence of glioma
Biochem Biophys Res Commun
(1991) - et al.
A variation in the structure of the protein-coding region of the human p53 gene
Gene
(1988) Von Recklinghausen neurofibromatosis
N Engl J Med
(1981)- et al.
Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)
N Engl J Med
(1988) - et al.
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
Nature
(1993) Mutation and cancer: statistical study of retinoblastoma
- et al.
Genetic origin of mutations predisposing to retinoblastoma
Science
(1985)
Chromosome aberrations and cancer
Science
(1991)
Mitotic recombination of chromosome 17 in astrocytomas
Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas
Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma
Cancer Res
(1989)
The p53 tumor suppressor protein: meeting review
Genes Dev
(1993)
Mutations in the p53 gene occur in diverse human tumour types
Nature
(1989)
p53 mutations in human cancers
Science
(1991)
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Nature
(1992)
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
Nat Genet
(1993)
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
Science
(1990)
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome
Nature
(1990)
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome
J Natl Cancer Inst
(1969)
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms
N Engl J Med
(1992)
Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma
N Engl J Med
(1992)
Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma
Inherited p53 gene mutations in breast cancer
Cancer Res
(1992)
p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
Cancer Res
(1992)
p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency
Cancer Res
(1992)
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma
Cancer Res
(1992)
Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products
Oncogene
(1991)
Cited by (71)
Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997
2003, European Journal of CancerMolecular Epidemiology of Primary Brain Tumors
2009, NeurotherapeuticsCitation Excerpt :Glial cell proliferation is considered important in gliomagenesis. Studies that looked at the correlations between cell cycle genes and glioma risk did not generate a clear pattern (Table 243,46-70). The positive association between EGF/EGFR and glioma risk was observed in majority of the case-control studies published.
The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
2022, International Journal of Molecular SciencesMalic enzyme 2 maintains protein stability of mutant p53 through 2-hydroxyglutarate
2022, Nature Metabolism
Copyright © 1995 Published by Elsevier Inc.